Dr. Steven Rosenberg

Chief, Surgery Branch/Senior Investigator
National Cancer Institute

Dr. Steven RosenbergÂ is Chief of Surgery at the National Cancer Institute.

Dr. Rosenberg pioneered the development of effective immunotherapies and gene therapies for patients with advanced cancers. His studies of the adoptive transfer of genetically modified lymphocytes have resulted in the regression of metastatic cancer in patients with melanoma, sarcomas and lymphomas.

His current research is aimed at defining the host immune response of patients to their cancers.